Gantsev, K. S., & Khmelevskiy, A. A. Combined Use of Bevacizumab + Interferon A-2 α in the Treatement of Patients with Disseminated Kidney Cancer in Comparison with an Active Monitoring Group. Bashkir State Medical University.
Chicago Style (17th ed.) CitationGantsev, K. Sh., and A. A. Khmelevskiy. Combined Use of Bevacizumab + Interferon A-2 α in the Treatement of Patients with Disseminated Kidney Cancer in Comparison with an Active Monitoring Group. Bashkir State Medical University.
MLA (9th ed.) CitationGantsev, K. Sh., and A. A. Khmelevskiy. Combined Use of Bevacizumab + Interferon A-2 α in the Treatement of Patients with Disseminated Kidney Cancer in Comparison with an Active Monitoring Group. Bashkir State Medical University.
Warning: These citations may not always be 100% accurate.